TileBio
Latest round
- Seed
Last raised
- Mar 2026
Total raised
- $2.2M
Investors
- 3
About TileBio
TileBio Ltd, founded in 2025, is headquartered in Glasgow, UK. The company develops advanced AI technologies for pathology, enhancing diagnostic processes.TileBio specializes in advanced artificial intelligence pathology solutions, centered on the development of large-scale foundation models that interpret histopathology images without the need for human labeling. Their core offering is an AI-learned visual language of tissue, designed to automate the understanding and interpretation of complex pathological data. This innovative approach enhances clinical diagnostics, biomarker discovery, and target development by allowing healthcare professionals to identify subtle patterns in tissue biology that are often imperceptible to the human eye. TileBio's technology is aimed at clinical laboratories, pharmaceutical companies, and research institutions globally, with a specific focus on addressing the challenges posed by the shortage of pathologists and the limitations of traditional, human-labeled datasets.TileBio generates revenue through strategic partnerships and direct sales of its AI pathology solutions to healthcare providers and research institutions. The business transactions typically involve subscription-based models for access to their proprietary AI tools and large language model services, allowing clients to integrate these technologies into their existing workflows. Clients include hospitals, clinical laboratories, and pharmaceutical firms that leverage the company’s unique offerings to improve diagnostic accuracy and accelerate research initiatives. The pricing structures are designed to accommodate various client needs, fostering scalable engagement that aligns with the extensive applications of their technology in diagnostics and drug discovery.6 million to expand its technical team, scale the training of its pathology foundation model, and establish early clinical, life sciences, and pharmaceutical partnerships. The company is focused on launching innovative new products aimed at improving diagnostic capabilities within the healthcare sector. Specifically, they intend to expand their market presence in North America, Europe, and Asia by 2027, aligning their growth strategy with the increasing demand for advanced diagnostic tools.
Who invested in TileBio
3 investors across 1 round
See all investors in TileBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 2, 2026
Amount
$2.2M
Investors
Questions about TileBio
Who invested in TileBio?
TileBio has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TileBio raised?
TileBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did TileBio last raise money?
TileBio's most recent round on record is a Seed, in Mar 2026.
What does TileBio do?
TileBio Ltd, founded in 2025, is headquartered in Glasgow, UK.
Where is TileBio headquartered?
TileBio is headquartered in Glasgow, UK.
Which VCs invest in companies like TileBio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at TileBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like TileBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.